Journal: Nature genetics
This study is a very large GWAS meta-analysis of thyroid diseases using genetic data from about 2.9 million individuals across 19 biobanks. The investigators examined five conditions: thyroid cancer, benign nodular goiter, Graves’ disease, lymphocytic thyroiditis, and primary hypothyroidism.
Key findings for clinical context:
- Genetic architecture
- Identified 883 independent loci associated with thyroid diseases, including 570 previously unreported.
- There are substantial genetic correlations between thyroid cancer, benign nodular goiter, and autoimmune thyroid diseases (reported rg range 0.16–0.97), indicating overlapping inherited susceptibility.
- Biologic insights
- Benign and malignant nodular disease share susceptibility involving telomere maintenance genes, suggesting that perturbations in telomere biology contribute broadly to nodule formation.
- Thyroid cancer–specific risk more strongly involved genes in cell cycle control, DNA repair, and DNA damage response, consistent with pathways of malignant transformation superimposed on nodular predisposition.
- The authors propose a paradigm where:
- Inherited telomere-related risk promotes benign and malignant nodularity.
- Additional inherited defects in genome maintenance pathways tilt toward malignant progression.
- Polygenic risk and tumor behavior
- Polygenic risk scores (PRS) for thyroid cancer were associated not just with disease occurrence but with adverse pathologic features:
- Larger tumor size
- Multifocality
- Lymph node metastases
- Extranodal extension
- Structural disease recurrence risk
- In a biobank setting, PRS could identify individuals enriched for more aggressive thyroid cancer phenotypes, suggesting potential utility for risk-stratified screening and surveillance in the future.
- Polygenic risk scores (PRS) for thyroid cancer were associated not just with disease occurrence but with adverse pathologic features:
Clinical relevance:
- Confirms that benign nodular disease and thyroid cancer share substantial inherited biology, but malignant disease is further shaped by DNA repair and cell-cycle pathways.
- Suggests that germline polygenic information may eventually contribute to:
- Identifying individuals at high risk for aggressive thyroid cancer.
- Refining decisions around screening intensity, diagnostic thresholds, and possibly extent of surgery or follow-up intensity, once PRS tools are validated and calibrated clinically.